nifedipine has been researched along with Cancer of Prostate in 10 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the efficacy of periprostatic nerve block (PNB) alone vs PNB combined with the local administration of a 1." | 2.74 | Periprostatic nerve block (PNB) alone vs PNB combined with an anaesthetic-myorelaxant agent cream for prostate biopsy: a prospective, randomized double-arm study. ( Cantiello, F; Di Meo, S; Fusco, F; Iannuzzo, M; Imbimbo, C; Imperatore, V; Mirone, V; Scibelli, G, 2009) |
| "Fourteen human cancer cell lines with and without DNA MMR derived from carcinomas of the colon, bladder, ovary and prostate were treated with CAI, vehicle or control drugs (nifedipine and 5-flurouracil)." | 1.35 | Selective sensitivity to carboxyamidotriazole by human tumor cell lines with DNA mismatch repair deficiency. ( Friedlander, ML; Kohn, EC; Qu, XJ; Yang, JL; Yu, Y, 2008) |
| "To better understand NT signaling in prostate cancer PC3 cells, blockers of voltage-gated and store-operated Ca2+ channels (VGCC and SOCC) were tested for effects on NT-binding and signaling." | 1.32 | Ca2+ channel blockers enhance neurotensin (NT) binding and inhibit NT-induced inositol phosphate formation in prostate cancer PC3 cells. ( Carraway, RE; Cochrane, DE; Gui, X, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Petrocellis, L | 1 |
| Arroyo, FJ | 1 |
| Orlando, P | 1 |
| Schiano Moriello, A | 1 |
| Vitale, RM | 1 |
| Amodeo, P | 1 |
| Sánchez, A | 1 |
| Roncero, C | 1 |
| Bianchini, G | 1 |
| Martín, MA | 1 |
| López-Alvarado, P | 1 |
| Menéndez, JC | 1 |
| Cantiello, F | 1 |
| Imperatore, V | 1 |
| Iannuzzo, M | 1 |
| Scibelli, G | 1 |
| Di Meo, S | 1 |
| Fusco, F | 1 |
| Imbimbo, C | 1 |
| Mirone, V | 1 |
| Carraway, RE | 1 |
| Gui, X | 1 |
| Cochrane, DE | 1 |
| Rekasi, Z | 1 |
| Czompoly, T | 1 |
| Schally, AV | 1 |
| Boldizsar, F | 1 |
| Varga, JL | 1 |
| Zarandi, M | 1 |
| Berki, T | 1 |
| Horvath, RA | 1 |
| Nemeth, P | 1 |
| Yang, JL | 1 |
| Qu, XJ | 1 |
| Yu, Y | 1 |
| Kohn, EC | 1 |
| Friedlander, ML | 1 |
| Sugimoto, K | 1 |
| Simard, J | 1 |
| Haagensen, DE | 1 |
| Labrie, F | 1 |
| Nickerson, T | 1 |
| Miyake, H | 1 |
| Gleave, ME | 1 |
| Pollak, M | 1 |
| Ando, Y | 1 |
| Tateishi, T | 1 |
| Sekido, Y | 1 |
| Yamamoto, T | 1 |
| Satoh, T | 1 |
| Hasegawa, Y | 1 |
| Kobayashi, S | 1 |
| Katsumata, Y | 1 |
| Shimokata, K | 1 |
| Saito, H | 1 |
| Chien, J | 1 |
| Shah, GV | 1 |
| Jan, CR | 1 |
| Jiann, BP | 1 |
| Lu, YC | 1 |
| Chang, HT | 1 |
| Su, W | 1 |
| Chen, WC | 1 |
| Yu, CC | 1 |
| Huang, JK | 1 |
1 trial available for nifedipine and Cancer of Prostate
| Article | Year |
|---|---|
Periprostatic nerve block (PNB) alone vs PNB combined with an anaesthetic-myorelaxant agent cream for prostate biopsy: a prospective, randomized double-arm study.
Topics: Aged; Anesthetics, Local; Biopsy, Needle; Drug Therapy, Combination; Epidemiologic Methods; Humans; | 2009 |
9 other studies available for nifedipine and Cancer of Prostate
| Article | Year |
|---|---|
Tetrahydroisoquinoline-Derived Urea and 2,5-Diketopiperazine Derivatives as Selective Antagonists of the Transient Receptor Potential Melastatin 8 (TRPM8) Channel Receptor and Antiprostate Cancer Agents.
Topics: Animals; Antineoplastic Agents; Calcium; Cell Proliferation; Diketopiperazines; Dose-Response Relati | 2016 |
Ca2+ channel blockers enhance neurotensin (NT) binding and inhibit NT-induced inositol phosphate formation in prostate cancer PC3 cells.
Topics: Binding Sites; Calcium; Calcium Channel Blockers; Endocytosis; Enzyme Inhibitors; Epidermal Growth F | 2003 |
Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathway.
Topics: Apoptosis; Calcium; Cell Line, Tumor; Edetic Acid; Flow Cytometry; Growth Hormone-Releasing Hormone; | 2005 |
Selective sensitivity to carboxyamidotriazole by human tumor cell lines with DNA mismatch repair deficiency.
Topics: Antineoplastic Agents; Apoptosis; Calcium Channel Blockers; Cell Cycle; Cell Line, Tumor; Chromosome | 2008 |
Inverse relationships between cell proliferation and basal or androgen-stimulated apolipoprotein D secretion in LNCaP human prostate cancer cells.
Topics: Apolipoproteins; Apolipoproteins D; Cell Division; Dihydrotestosterone; Humans; Male; Nifedipine; Pr | 1994 |
Castration-induced apoptosis of androgen-dependent shionogi carcinoma is associated with increased expression of genes encoding insulin-like growth factor-binding proteins.
Topics: Amlodipine; Animals; Apoptosis; Calcium Channel Blockers; Calcium Signaling; Carcinoma; Gene Express | 1999 |
Re: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4.
Topics: Asian People; Calcium Channel Blockers; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Enzy | 1999 |
Role of stimulatory guanine nucleotide binding protein (GSalpha) in proliferation of PC-3M prostate cancer cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenylyl Cyclases; Blotting, Western; Calcitonin; Calcium Ch | 2001 |
Effect of the organotin compound triethyltin on Ca2+ handling in human prostate cancer cells.
Topics: Calcium; Calcium-Transporting ATPases; Dose-Response Relationship, Drug; Drug Antagonism; Fura-2; Hu | 2002 |